BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 18826963)

  • 1. PROKR2 missense mutations associated with Kallmann syndrome impair receptor signalling activity.
    Monnier C; Dodé C; Fabre L; Teixeira L; Labesse G; Pin JP; Hardelin JP; Rondard P
    Hum Mol Genet; 2009 Jan; 18(1):75-81. PubMed ID: 18826963
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutations in prokineticin 2 and prokineticin receptor 2 genes in human gonadotrophin-releasing hormone deficiency: molecular genetics and clinical spectrum.
    Cole LW; Sidis Y; Zhang C; Quinton R; Plummer L; Pignatelli D; Hughes VA; Dwyer AA; Raivio T; Hayes FJ; Seminara SB; Huot C; Alos N; Speiser P; Takeshita A; Van Vliet G; Pearce S; Crowley WF; Zhou QY; Pitteloud N
    J Clin Endocrinol Metab; 2008 Sep; 93(9):3551-9. PubMed ID: 18559922
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biased signaling through G-protein-coupled PROKR2 receptors harboring missense mutations.
    Sbai O; Monnier C; Dodé C; Pin JP; Hardelin JP; Rondard P
    FASEB J; 2014 Aug; 28(8):3734-44. PubMed ID: 24830383
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss-of-function mutations in the genes encoding prokineticin-2 or prokineticin receptor-2 cause autosomal recessive Kallmann syndrome.
    Abreu AP; Trarbach EB; de Castro M; Frade Costa EM; Versiani B; Matias Baptista MT; Garmes HM; Mendonca BB; Latronico AC
    J Clin Endocrinol Metab; 2008 Oct; 93(10):4113-8. PubMed ID: 18682503
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kallmann syndrome: mutations in the genes encoding prokineticin-2 and prokineticin receptor-2.
    Dodé C; Teixeira L; Levilliers J; Fouveaut C; Bouchard P; Kottler ML; Lespinasse J; Lienhardt-Roussie A; Mathieu M; Moerman A; Morgan G; Murat A; Toublanc JE; Wolczynski S; Delpech M; Petit C; Young J; Hardelin JP
    PLoS Genet; 2006 Oct; 2(10):e175. PubMed ID: 17054399
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence of the importance of the first intracellular loop of prokineticin receptor 2 in receptor function.
    Abreu AP; Noel SD; Xu S; Carroll RS; Latronico AC; Kaiser UB
    Mol Endocrinol; 2012 Aug; 26(8):1417-27. PubMed ID: 22745195
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kallmann syndrome caused by mutations in the PROK2 and PROKR2 genes: pathophysiology and genotype-phenotype correlations.
    Sarfati J; Dodé C; Young J
    Front Horm Res; 2010; 39():121-132. PubMed ID: 20389090
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Variations in PROKR2, but not PROK2, are associated with hypopituitarism and septo-optic dysplasia.
    McCabe MJ; Gaston-Massuet C; Gregory LC; Alatzoglou KS; Tziaferi V; Sbai O; Rondard P; Masumoto KH; Nagano M; Shigeyoshi Y; Pfeifer M; Hulse T; Buchanan CR; Pitteloud N; Martinez-Barbera JP; Dattani MT
    J Clin Endocrinol Metab; 2013 Mar; 98(3):E547-57. PubMed ID: 23386640
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The complex genetics of Kallmann syndrome: KAL1, FGFR1, FGF8, PROKR2, PROK2, et al.
    Hardelin JP; Dodé C
    Sex Dev; 2008; 2(4-5):181-93. PubMed ID: 18987492
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kallmann syndrome with a Tyr113His PROKR2 mutation.
    Ha JH; Lee S; Kim Y; Moon JI; Seo J; Jang JH; Cho EH; Kim JM; Rhee BD; Ko KS; Yoo SJ; Won JC
    Medicine (Baltimore); 2017 Sep; 96(35):e7974. PubMed ID: 28858133
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic analysis in patients with Kallmann syndrome: coexistence of mutations in prokineticin receptor 2 and KAL1.
    Canto P; Munguía P; Söderlund D; Castro JJ; Méndez JP
    J Androl; 2009; 30(1):41-5. PubMed ID: 18723471
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional rescue of Kallmann syndrome-associated prokineticin receptor 2 (PKR2) mutants deficient in trafficking.
    Chen DN; Ma YT; Liu H; Zhou QY; Li JD
    J Biol Chem; 2014 May; 289(22):15518-26. PubMed ID: 24753254
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparative phenotypic study of kallmann syndrome patients carrying monoallelic and biallelic mutations in the prokineticin 2 or prokineticin receptor 2 genes.
    Sarfati J; Guiochon-Mantel A; Rondard P; Arnulf I; Garcia-Piñero A; Wolczynski S; Brailly-Tabard S; Bidet M; Ramos-Arroyo M; Mathieu M; Lienhardt-Roussie A; Morgan G; Turki Z; Bremont C; Lespinasse J; Du Boullay H; Chabbert-Buffet N; Jacquemont S; Reach G; De Talence N; Tonella P; Conrad B; Despert F; Delobel B; Brue T; Bouvattier C; Cabrol S; Pugeat M; Murat A; Bouchard P; Hardelin JP; Dodé C; Young J
    J Clin Endocrinol Metab; 2010 Feb; 95(2):659-69. PubMed ID: 20022991
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic overlap in Kallmann syndrome, combined pituitary hormone deficiency, and septo-optic dysplasia.
    Raivio T; Avbelj M; McCabe MJ; Romero CJ; Dwyer AA; Tommiska J; Sykiotis GP; Gregory LC; Diaczok D; Tziaferi V; Elting MW; Padidela R; Plummer L; Martin C; Feng B; Zhang C; Zhou QY; Chen H; Mohammadi M; Quinton R; Sidis Y; Radovick S; Dattani MT; Pitteloud N
    J Clin Endocrinol Metab; 2012 Apr; 97(4):E694-9. PubMed ID: 22319038
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of prokineticins in the pathogenesis of hypogonadotropic hypogonadism.
    Abreu AP; Kaiser UB; Latronico AC
    Neuroendocrinology; 2010; 91(4):283-90. PubMed ID: 20502053
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional analysis of the distal region of the third intracellular loop of PROKR2.
    Zhou XT; Chen DN; Xie ZQ; Peng Z; Xia KD; Liu HD; Liu W; Su B; Li JD
    Biochem Biophys Res Commun; 2013 Sep; 439(1):12-7. PubMed ID: 23969157
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diversity in fibroblast growth factor receptor 1 regulation: learning from the investigation of Kallmann syndrome.
    Kim SH; Hu Y; Cadman S; Bouloux P
    J Neuroendocrinol; 2008 Feb; 20(2):141-63. PubMed ID: 18034870
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss-of-function mutation in the prokineticin 2 gene causes Kallmann syndrome and normosmic idiopathic hypogonadotropic hypogonadism.
    Pitteloud N; Zhang C; Pignatelli D; Li JD; Raivio T; Cole LW; Plummer L; Jacobson-Dickman EE; Mellon PL; Zhou QY; Crowley WF
    Proc Natl Acad Sci U S A; 2007 Oct; 104(44):17447-52. PubMed ID: 17959774
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Greater prevalence of PROKR2 mutations in Kallmann syndrome patients from the Maghreb than in European patients.
    Sarfati J; Fouveaut C; Leroy C; Jeanpierre M; Hardelin JP; Dodé C
    Eur J Endocrinol; 2013 Dec; 169(6):805-9. PubMed ID: 24031091
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biallelic mutations in the prokineticin-2 gene in two sporadic cases of Kallmann syndrome.
    Leroy C; Fouveaut C; Leclercq S; Jacquemont S; Boullay HD; Lespinasse J; Delpech M; Dupont JM; Hardelin JP; Dodé C
    Eur J Hum Genet; 2008 Jul; 16(7):865-8. PubMed ID: 18285834
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.